Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosulpiride Pantoprazole Sodium Injection in Peptic Ulcer Bleeding
CTR20190387Phase 2Completed
- Sponsor
- Hunan Mingrui Pharmaceutical
- Start
- Mar 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of s-pantoprazole in Peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), Hyperacidity, Zollinger–Ellison syndrome (ZES), upper gastrointestinal bleeding (UGIB), sponsored by Hunan Mingrui Pharmaceutical. Started Mar 2019; status: completed.
02
Drugs
s-pantoprazole
03
Conditions
Peptic ulcer disease (PUD)gastroesophageal reflux disease (GERD)HyperacidityZollinger–Ellison syndrome (ZES)upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on CTR20190387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190387.